HANGZHOU, China, July 8, 2026 /PRNewswire/ -- On July 8, the study of Betta's ensartinib as postoperative adjuvant therapy for patients with stage IB–IIIB (T3N2M0) ALK-positive non-small cell lung cancer (NSCLC), known as the ELEVATE study, was published online in full in The New England...
Hence then, the article about groundbreaking achievement study of ensartinib as postoperative adjuvant therapy published in the new england journal of medicine was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine )
Also on site :
- Soul Hitmaker Behind One of the ‘Greatest’ 1974 R&B Chart-Toppers “Let’s Straighten It Out,” Dies at 86
- Doctor who reportedly wrote a paper on violent teens killed in alleged plot involving her daughter and friends
- Katie Miller throws Karoline Leavitt a party with White House lectern cake as speculation continues over replacement